Published in
Taylor & Francis, Expert Opinion on Pharmacotherapy, 11(20), p. 1309-1320, 2019
DOI: 10.1080/14656566.2019.1623879
Links
Tools
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?
Journal article published in 2019 by
Matteo Foschi 
,
Alessandra Lugaresi
,
Alessandra Lugaresi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 